Re: Geng et al.: XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a meta-analysis (Urology 2009;74:648-653)

Urology. 2011 Aug;78(2):481-2. doi: 10.1016/j.urology.2011.03.050.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • DNA-Binding Proteins / genetics*
  • Humans
  • Male
  • Polymorphism, Genetic*
  • Prostatic Neoplasms / epidemiology*
  • Prostatic Neoplasms / genetics*

Substances

  • DNA-Binding Proteins